Independently Owned, Locally Grown, Community Loved
Mackay Hospital and Health Service (HHS) trial sub-investigator and senior medical officer (emergency) Dr Olurotimi Akinola, clinical trials nurse Alta Neethling and senior staff specialist (emergency) and principal investigator Dr Sunday Sofola-Orukotan. Photo supplied
Mackay Base Hospital has become one of three sites across Australia recruiting patients for a clinical trial investigating a potential new drug treatment aimed at improving recovery time following concussion.
The clinical trial will assess the safety and effectiveness of an investigational medication designed to treat concussion and potentially support faster recovery for those affected.
Mackay Hospital and Health Service (HHS) Senior Staff Specialist (Emergency) and Principal Investigator Dr Sunday Sofola-Orukotan said concussion was a very common condition which could happen to anyone, anywhere, but was more frequently associated with contact sports such as football.
“It’s very common with sporting activities and the rate of presentations of head injuries increases during the rugby season,” Dr Sofola-Orukotan said.
Trial sub-investigator and Mackay HHS senior medical officer (emergency) Dr Olurotimi Akinola said concussion presentations in the ED could also be the result of falls and trips.
“We see it very often in elderly patients,” Dr Akinola said.
“That’s why a study like this is important because it gives us the opportunity to investigate whether a new treatment may improve a patient’s recovery outcomes.”
“Generally, most patients with concussion recovered within a few days, but some experienced persistent symptoms such as headaches, dizziness and concentration and memory issues,” he said.
“We see people with post-concussive syndrome who have had ongoing symptoms for months and it's affecting their livelihood and day-to-day activities,” Dr Akinola said.
There are currently no approved pharmaceutical treatments for concussion available in Australia with recovery focused on rest and symptom relief.
This clinical trial would investigate the safety and efficacy of a new drug in the treatment of mild traumatic brain injury and trial participants would receive either the investigational drug or placebo alongside standard care.
During his training in Nigeria, Dr Sofola-Orukotan had been involved in another clinical trial and collected data for a study into reducing bleeding in traumatic brain injuries.
“This study is very similar to what I’ve done before so I see it as an opportunity to bring this type of research to the Mackay region to benefit our patients,” he said.
Anyone interested in learning more about the clinical trial can contact the Clinical Trials Unit on 4951 7561 or email mackay-clinical-trials@health.qld.gov.au
Publishers Indemnity. Any individual or entity that places advertising, supplies copy material, or submits editorial content to Core Life Publishing agrees and undertakes to ensure that all such material:- Does not infringe upon any copyright, trademark, or other intellectual property rights;- Is free from any content that could be considered defamatory, libelous, or slanderous;- Does not infringe upon any rights related to privacy or breach of confidence;- Contains no obscene, indecent, or otherwise unlawful material;- Complies fully with the Trade Practices Act and all other applicable laws, regulations, or statutes.Furthermore, by submitting or placing such material, these individuals or entities agree to indemnify and hold harmless the publisher, Core Publishing and Events Pty Ltd, and/or its agents from and against any and all investigations, claims, demands, liabilities, damages, costs, or judgments arising out of or in connection with the material provided. All material is believed to be accurate at the time of printing and remains the copyright of Core Publishing and Events Pty Ltd.
© 2026 Mackay and Whitsunday Life Pty Ltd.
